Full Text Journal Articles in
Journal Urol Oncol

Advertisement

Find full text journal articles






A history of the Society of Urologic Oncology.

Paul H Lange, Michael S Cookson, Paul F Schellhammer, Michael J Droller,

This narrative of the history of the Society of Urologic Oncology (SUO) presents the story of the founding and development of this organization and the creation and establishment of its initiatives and programs. It includes a description of how "Urologic Oncology: Seminars and Original Investigations" came to be designated as ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



The additive value of mpMRI on prostate cancer detection: Comparison between patients with and without a suspicious digital rectal examination (DRE).

Nativ Omri, Shefler Alex, Bejar Jacob, Nativ Ofer,

<h4>Purpose</h4>Diagnosis of prostate cancer (CaP) is based on digital rectal examination (DRE) and/or elevated prostate specific antigen (PSA) level. This approach lacks sensitivity and specificity and is associated with many negative biopsies, high rate of diagnosing clinically insignificant disease and lacks accuracy to predict clinically significant (CS) cancer. The addition ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Do patients with a PI-RADS 5 lesion identified on magnetic resonance imaging require systematic biopsy in addition to targeted biopsy?

Justin N Drobish, Mark D Bevill, Chad R Tracy, Shawn M Sexton, Maheen Rajput, Catherine M Metz, Paul T Gellhaus,

<h4>Introduction</h4>Magnetic Resonance Imaging (MRI)-targeted prostate biopsy (MRI-TB) improves the detection of prostate cancer. These biopsies typically involve both a 12-core systematic biopsy (SB) and MRI-TB of the lesion. Since the majority of PI-RADS 5 lesions represent clinically significant cancers, the utility of SB in addition to MRI-TB is unclear. We ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review.

Ekaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, Victor M Schuettfort, Fahad Quhal, Hadi Mostafaei, Reza Sari Motlangh, Satoshi Katayama, Nico C Grossmann, Marco Moschini, Dmitry Enikeev, Shahrokh F Shariat,

<h4>Purpose</h4>The present systematic review aimed to identify prognostic values of tissue-based biomarkers in patients treated with neoadjuvant systemic therapy (NAST), including chemotherapy (NAC) and checkpoint inhibitors (NAI) for urothelial carcinoma of the bladder (UCB).<h4>Material and methods</h4>The PubMed, Web of Science, and Scopus databases were searched in August 2020 according to ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Neoadjuvant chemotherapy in bladder cancer: Clinical benefit observed in prospective trials computed with restricted mean survival times.

Zachary R McCaw, Anobel Y Odisho, Hemant Chaparala, Ming Yin, Jordan Cloyd, Robert S Svatek, William E Carson, Cheryl T Lee, Debasish Sundi,

<h4>Purpose</h4>Neoadjuvant chemotherapy (NAC) is the standard of care for eligible patients with cT2-4a N0 M0 bladder cancer undergoing surgical resection. The extent to which (and if) NAC increases patient survival is not clear as clinical trials and meta-analyses have generated both negative and "borderline" positive results. The novel method of ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Investigating the association between the urinary microbiome and bladder cancer: An exploratory study.

Ahmed A Hussein, Ahmed S Elsayed, Mohammad Durrani, Zhe Jing, Umar Iqbal, Eduardo Cortes Gomez, Prashant K Singh, Song Liu, Gary Smith, Li Tang, Khurshid A Guru,

<h4>Introduction</h4>We sought to investigate the association between the urinary microbiome and bladder cancer, including the difference between nonmuscle-invasive (NMIBC) and muscle-invasive (MIBC) bladder cancer, and Bacillus Calmette Guerin (BCG) responsive vs. BCG-refractory NMIBC.<h4>Methods</h4>Urine specimens were collected from consecutive patients with bladder cancer and healthy volunteers. Urine samples were analyzed using ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Outcomes of palliative cystectomy in patients with locally advanced pT4 bladder cancer.

Phillipp Maisch, Lukas Lunger, Charlotte Düwel, Sebastian C Schmid, Thomas Horn, Jürgen E Gschwend, Andreas Sauter, Matthias M Heck,

<h4>Background</h4>Radical cystectomy (Cx) is the standard of care for muscle-invasive bladder cancer (BCa). In locally advanced pT4 BCa the oncologic outcome is inexplicit but Cx may be necessary for palliation.<h4>Objectives</h4>The aim of this retrospective study was to evaluate the outcomes of Cx performed in patients with locally advanced pT4 BCa ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.

Giancarlo Marra, Robert Jeffrey Karnes, Giorgio Calleris, Marco Oderda, Paolo Alessio, Anna Palazzetti, Antonino Battaglia, Francesca Pisano, Stefania Munegato, Fernando Munoz, Claudia Filippini, Umberto Ricardi, Estefania Linares, Rafael Sanchez-Salas, Sanchia Goonewardene, Prokar Dasgupta, Ben Challacombe, Rick Popert, Declan Cahill, David Gillatt, Raj Persad, Juan Palou, Steven Joniau, Salvatore Smelzo, Thierry Piechaud, Alexandre De La Taille, Morgan Roupret, Simone Albisinni, Roland van Velthoven, Alessandro Morlacco, Sharma Vidit, Giorgio Gandaglia, Alexander Mottrie, Joseph Smith, Shreyas Joshi, Gabriel Fiscus, Andre Berger, Monish Aron, Andre Abreu, Inderbir S Gill, Henk Van Der Poel, Derya Tilki, Declan Murphy, Nathan Lawrentschuk, John Davis, Paolo Gontero,

<h4>Background</h4>Salvage radical prostatectomy (sRP) historically yields poor functional outcomes and high complication rates. However, recent reports on robotic sRP show improved results. Our objectives were to evaluate sRP oncological outcomes and predictors of positive margins and biochemical recurrence (BCR).<h4>Methods</h4>We retrospectively collected data of sRP for recurrent prostate cancer after local ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Correlates of refusal of radical cystectomy in patients with muscle-invasive bladder cancer.

Ahmed Elshabrawy, Hanzhang Wang, Arpan Satsangi, Karen Wheeler, Chethan Ramamurthy, Deepak Pruthi, Dharam Kaushik, Michael Liss, Jonathan Gelfond, Roman Fernandez, John Gore, Robert Svatek, Ahmed M Mansour,

<h4>Purpose</h4>To evaluate factors associated with radical cystectomy (RC) refusal, subsequent treatment decisions, and their influence on overall survival (OS).<h4>Materials and methods</h4>We queried the National Cancer Database for patients with non-metastatic muscle-invasive bladder cancer (MIBC), cT2-T4M0. Patients who refused recommended RC were further stratified by treatment into chemotherapy, radiation therapy, chemoradiotherapy, ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Integration of electronic pathology reporting with clinical trial matching for advanced prostate cancer.

Hala T Borno, Christine Duffy, Sylvia Zhang, Alison J Canchola, Zinnia Loya, Todd Golden, Debora L Oh, Anobel Y Odisho, Scarlett Gomez,

<h4>Introduction</h4>Racial/ethnic diversity in prostate cancer (CaP) clinical trials (CTs) is essential to address CaP disparities. California Cancer Registry mandated electronic reporting (e-path) of structured data elements from pathologists diagnosing cancer thereby creating an opportunity to identify and approach patients rapidly. This study tested the utility of an online CT matching ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging.

E Di Trapani, S Luzzago, G Peveri, M Catellani, M Ferro, G Cordima, F A Mistretta, R Bianchi, G Cozzi, S Alessi, D V Matei, V Bagnardi, G Petralia, G Musi, O De Cobelli,

<h4>Purpose</h4>To develop a novel risk tool that allows the prediction of lymph node invasion (LNI) among patients with prostate cancer (PCa) treated with robot-assisted radical prostatectomy (RARP) and extended pelvic lymph node dissection (ePLND).<h4>Methods</h4>We retrospectively identified 742 patients treated with RARP + ePLND at a single center between 2012 and 2018. All ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Racial and socioeconomic disparities in retroperitoneal lymph node dissection and survival in nonseminomatous germ cell tumor: A population-based study.

Hriday P Bhambhvani, Daniel R Greenberg, Alex M Kasman, Mindy C DeRouen, Iona Cheng, Michael L Eisenberg, Sumit A Shah,

<h4>Background</h4>Though testicular cancer is the most common cancer in young men, there is a paucity of epidemiologic studies examining sociodemographic disparities in adjuvant therapy and outcomes. We examined the associations of sociodemographic factors with retroperitoneal lymph node dissection (RPLND) and survival among patients with nonseminomatous germ cell tumors (NSGCTs).<h4>Methods</h4>Within the ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Meditative and mind-body practice among patients with genitourinary malignancy.

William C Daly, Paul K J Han, Matthew Hayn, Stephen T Ryan, Moritz H Hansen, Joshua P Linscott, Quoc-Dien Trinh, Jesse D Sammon,

<h4>Introduction and objective</h4>Research on the utility of meditative and mind-body (MB) practices has increased dramatically in the last two decades and both have been suggested as useful adjuncts in coping with stressors associated with cancer survivorship. There exists little data on use among genitourinary (GU) cancer survivors. This study seeks ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



The spinal distribution of metastatic renal cell carcinoma: Support for locoregional rather than arterial hematogenous mode of early bony dissemination.

Kyrollis Attalla, Cihan Duzgol, Lily McLaughlin, Jessica Flynn, Irina Ostrovnaya, Paul Russo, Mark H Bilsky, A Ari Hakimi, Nelson S Moss,

<h4>Background</h4>Quantifying the degree to which spinal involvement of metastatic renal cell carcinoma (mRCC) is a locoregional phenomenon vs. a hematogenous, bone-specific affinity has implications for prognosis and antimetastatic therapy.<h4>Objective</h4>To investigate the distribution of spinal metastasis in mRCC and to explore relationships between clinical factors and patterns of spinal spread.<h4>Methods</h4>Patients with ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Characterization of perioperative androgen profiles in men with bladder cancer undergoing radical cystectomy.

Woodson W Smelser, Joseph Hogan Randall, Joshua Caldwell, Katherine Glavin, Eugene K Lee, Ajay Nangia, Jeffrey M Holzbeierlein,

<h4>Background</h4>Prior studies have demonstrated declines in androgen levels in men with cancer and patients undergoing anesthesia and surgery. In this study, we hypothesized that decreased serum androgen levels are prevalent in male patients undergoing radical cystectomy (RC) for bladder cancer and that it persists in the postoperative period. We characterized ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study.

Omer Onur Cakir, Fabio Castiglione, Zafer Tandogdu, Justin Collins, Hussain M Alnajjar, Clare Akers, Maarten Albersen, Constantine Alifrangis, Benjamin Ayres, Oscar Brouwer, Ivor Cullen, Peter Hawkey, Jakob Kristian Jakobsen, Truls Erik Bjerklund Johansen, Odunayo Kalejaiye, Asheesh Kaul, Bela Köves, Vivekanandan Kumar, Mariangela Mancini, Anita Vanessa Mitra, Arie Parnham, Edoardo Pozzi, Chris Protzel, Vijay K Sangar, Florian Wagenlehner, Asif Muneer,

<h4>Objectives</h4>To develop an international consensus on managing penile cancer patients during the COVID-19 acute waves. A major concern for patients with penile cancer during the coronavirus disease 2019 (COVID-19) pandemic is how the enforced safety measures will affect their disease management. Delays in diagnosis and treatment initiation may have an ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Diet and lifestyles in patients with prostate cancer.

Tomoyuki Kawada,

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review.

Jur Robert Erica Wolfs, Tom Johannes Noël Hermans, Evert Louwerens Koldewijn, Daan van de Kerkhof,

Non-muscle-invasive bladder cancer (NMIBC) is accompanied with high incidence and recurrence rates. The extensive need for cystoscopic follow up causes substantial patient discomfort and leads to a high economic burden. Cytology of exfoliated tumor cells in urine is not able to safely reduce or replace the amount of cystoscopies. Here, ... Read more >>

Urol Oncol (Urologic oncology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Systemic therapy and COVID19: Immunotherapy and chemotherapy.

Shuchi Gulati, Ramya Muddasani, Paulo Gustavo Bergerot, Sumanta K Pal,

As the novel severe acute respiratory syndrome coronavirus-2 related pandemic - Corona Virus Disease 2019 (COVID-19) has emerged, decision making in the context of cancer treatment has become more complex. The apprehension of using drugs that could adversely affect infected patients, the risk of not using life-saving treatments and the ... Read more >>

Urol Oncol (Urologic oncology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama,

<h4>Objective</h4>The present study aimed to evaluate oncologic outcomes, patient-reported outcomes (PROs), and frailty in older adult patients aged ≥75 years who underwent robot-assisted radical prostatectomy (RARP).<h4>Materials and methods</h4>This retrospective study reviewed the medical records of 752 patients who underwent RARP from July 2011 to May 2020. The PROs were evaluated ... Read more >>

Urol Oncol (Urologic oncology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Clinical utility of the AJCC 8th edition pT1 subclassification and impact on practice patterns in stage I seminoma.

Rohit R Badia, Solomon Woldu, Hiten D Patel, Nirmish Singla, Arnav Srivastava, Joseph G Cheaib, Phillip M Pierorazio, Aditya Bagrodia,

<h4>Background</h4>The American Joint Committee on Cancer 8<sup>th</sup> edition staging guidelines for testicular cancer established a 3 cm cutoff to subclassify stage T1 seminomas (<3 cm = pT1a and ≥3 cm = pT1b). The efficacy of this cutoff in predicting metastatic disease and impact on treatment patterns have not been studied.<h4>Methods</h4>We retrospectively reviewed patients with ... Read more >>

Urol Oncol (Urologic oncology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Factors associated with higher prostate biopsy yield: when is software-assisted fusion MRI-targeting necessary?

Grant M Henning, Joel M Vetter, Joshua A Sterling, Gerald L Andriole, Isaac Y Kim, Eric H Kim,

<h4>Objective</h4>To evaluate the addition of software-assisted fusion magnetic resonance imaging (MRI) targeted biopsy to systematic biopsy and determine clinical and imaging factors associated with improved prostate cancer (PCa) detection.<h4>Methods</h4>We analyzed 454 patients who had prostate MRI and underwent combined systematic and software-assisted fusion MRI-targeted biopsy at 2 academic centers between ... Read more >>

Urol Oncol (Urologic oncology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.

Donna L Berry, Fangxin Hong, Traci M Blonquist, Barbara Halpenny, Niya Xiong, Christopher P Filson, Viraj A Master, Martin G Sanda, Peter Chang, Gary W Chien, Randy A Jones, Tracey L Krupski, Seth Wolpin, Leslie Wilson, Julia H Hayes, Quoc-Dien Trinh, Mitchell Sokoloff,

<h4>Introduction</h4>Men diagnosed with localized prostate cancer must navigate a highly preference-sensitive decision between treatment options with varying adverse outcome profiles. We evaluated whether use of a decision support tool previously shown to decrease decisional conflict also impacted the secondary outcome of post-treatment decision regret.<h4>Methods</h4>Participants were randomized to receive personalized decision ... Read more >>

Urol Oncol (Urologic oncology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Pathology grade influences competing mortality risks in elderly men with prostate cancer.

Muhammad Umar Alam, Jatinder Kumar, Daniel Norez, Karthik Tanneru, Seyed Behzad Jazayeri, Soroush Bazargani, Joseph Costa, Mark Bandyk, Hariharan Palayapalayam Ganapathi, Shahriar Koochekpour, Shiva Gautam, K C Balaji,

<h4>Background</h4>Recent guidelines recommend active management of prostate cancer (CaP), especially high-risk disease, in elderly men. However, descriptive data from a large cohort with extended follow up on the risk of death from CaP in men diagnosed over 70 years of age and its relationship to Gleason score (GS) and serum ... Read more >>

Urol Oncol (Urologic oncology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



"Future role of [18F]-FDG PET/CT in patients with bladder cancer in the new era of neoadjuvant immunotherapy?"

Antoine Girard, Helena Vila Reyes, Laurent Dercle, Mathieu Rouanne,

Urol Oncol (Urologic oncology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
1.0761 s